Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.

PubWeight™: 1.24‹?› | Rank: Top 10%

🔗 View Article (PMID 9724117)

Published in J Neurosurg on September 01, 1998

Authors

E Galanis1, J C Buckner, R P Dinapoli, B W Scheithauer, R B Jenkins, C H Wang, J R O'Fallon, G Farr

Author Affiliations

1: Department of Oncology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.

Articles citing this

Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo. Stem Cells (2010) 1.29

Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity. J Neurooncol (2009) 1.25

Adult gliosarcoma: epidemiology, natural history, and factors associated with outcome. Neuro Oncol (2008) 1.19

Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter. Am J Pathol (1999) 1.11

Thymoma and multiple malignancies: a case of five synchronous neoplasms and literature review. Clin Med Res (2003) 0.95

What next for newly diagnosed glioblastoma? Future Oncol (2015) 0.94

An individual patient data meta-analysis on characteristics, treatments and outcomes of glioblastoma/ gliosarcoma patients with metastases outside of the central nervous system. PLoS One (2015) 0.88

Post-Treatment Gliosarcoma Extension into the Pterygomaxillary Fossa: Literature Review and Case Report. Cureus (2016) 0.85

Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma. Br J Cancer (2004) 0.85

Childhood's gliosarcomas: pathological and therapeutical considerations on three cases and critical review of the literature. Childs Nerv Syst (2006) 0.85

Gliosarcoma: A rare primary CNS tumor. Presentation of two cases. Rep Pract Oncol Radiother (2010) 0.85

Primary gliosarcoma of the brain: radiologic and histopathologic features. Neuroradiol J (2013) 0.84

Posterior fossa involvement in a recurrent gliosarcoma. J Neurosci Rural Pract (2012) 0.83

Impact of changing trends of treatment on outcome of cerebral gliosarcoma: A tertiary care centre experience. South Asian J Cancer (2015) 0.76

Gliosarcoma with Primary Skull Base Invasion. Case Rep Radiol (2016) 0.75

Brachium Pontis Gliosarcoma With Well-Differentiated Cartilaginous Tissue: A Case Report. Medicine (Baltimore) (2015) 0.75

Perioperative single photon emission computed tomography in predicting survival of malignant glioma patients. Oncol Lett (2012) 0.75

Gliosarcoma: a study of four cases. Rare Tumors (2010) 0.75

Articles by these authors

Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer (1986) 8.57

Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke (1999) 7.93

Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med (1999) 7.81

The new WHO classification of brain tumours. Brain Pathol (1993) 7.16

Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med (1998) 7.12

Studies on the mechanism by which cyanine dyes measure membrane potential in red blood cells and phosphatidylcholine vesicles. Biochemistry (1974) 6.97

Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet (2005) 4.14

Changes in axon fluorescence during activity: molecular probes of membrane potential. J Membr Biol (1974) 3.80

Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol (2000) 3.61

Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer (1997) 3.58

Changes in absorption, fluorescence, dichroism, and Birefringence in stained giant axons: : optical measurement of membrane potential. J Membr Biol (1977) 3.49

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst (2001) 3.37

Sporadic medulloblastomas contain PTCH mutations. Cancer Res (1997) 3.22

Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain (2008) 3.05

Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys (1998) 2.99

A strain-driven morphotropic phase boundary in BiFeO3. Science (2009) 2.95

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst (2001) 2.90

Megestrol acetate for the prevention of hot flashes. N Engl J Med (1994) 2.72

Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet (1996) 2.67

Meningeal hemangiopericytoma: histopathological features, treatment, and long-term follow-up of 44 cases. Neurosurgery (1989) 2.66

Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med (1979) 2.63

Extrapulmonary small cell carcinoma. Cancer (1997) 2.61

The characteristics and needs of sheltered homeless and low-income housed mothers. JAMA (1996) 2.53

p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol (1999) 2.47

Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery (1988) 2.41

"Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer (1999) 2.40

Identification and Estimation of Catabolic Pathways of Glucose in Fruits. Plant Physiol (1958) 2.39

Improvements in optical methods for measuring rapid changes in membrane potential. J Membr Biol (1981) 2.34

Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg (1987) 2.32

A homeobox gene essential for zebrafish notochord development. Nature (1995) 2.25

Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol (1998) 2.24

Homelessness in female-headed families: childhood and adult risk and protective factors. Am J Public Health (1997) 2.22

Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Cancer (1995) 2.20

Pituicytoma: a distinctive low-grade glioma of the neurohypophysis. Am J Surg Pathol (2000) 2.19

Automated fluorescence polarization immunoassay for monitoring vancomycin. Ther Drug Monit (1983) 2.11

Human epithelial ovarian cancer allelotype. Cancer Res (1993) 2.08

Myxopapillary ependymoma. A clinicopathologic and immunocytochemical study of 77 cases. Cancer (1985) 2.03

Brain metastases from colorectal carcinoma. The long term survivors. Cancer (1996) 2.01

Thymoma. A clinicopathologic review. Cancer (1987) 1.98

Papillary glioneuronal tumor: a new variant of mixed neuronal-glial neoplasm. Am J Surg Pathol (1998) 1.97

Olfactory neuroblastoma. An immunohistochemical, ultrastructural, and flow cytometric study. Cancer (1995) 1.97

Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol (1993) 1.93

Primary melanocytic neoplasms of the central nervous systems. Am J Surg Pathol (1999) 1.93

Unruptured left ventricular pseudoaneurysm following myocardial infarction. Heart (1998) 1.92

Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene (1999) 1.91

Small cell architecture--a histological equivalent of EGFR amplification in glioblastoma multiforme? J Neuropathol Exp Neurol (2001) 1.91

Prevalence of mental health and substance use disorders among homeless and low-income housed mothers. Am J Psychiatry (1998) 1.88

Mechanism of potential-dependent light absorption changes of lipid bilayer membranes in the presence of cyanine and oxonol dyes. J Membr Biol (1977) 1.85

Histopathology, classification, and grading of gliomas. Glia (1995) 1.84

Differential SMN2 expression associated with SMA severity. Nat Genet (1998) 1.84

A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol (2000) 1.81

Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer. Clin Cancer Res (2000) 1.81

Intraventricular perineurioma: case report. Neurosurgery (1998) 1.81

Solitary fibrous tumor of the meninges: a lesion distinct from fibrous meningioma. A clinicopathologic and immunohistochemical study. Am J Clin Pathol (1996) 1.81

Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res (1998) 1.80

Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol (1997) 1.79

Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol (1982) 1.77

A retrospective analysis of pituitary apoplexy. Neurosurgery (1993) 1.76

Management of recurrent meningeal hemangiopericytoma. Cancer (1998) 1.76

Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message. J Clin Oncol (2001) 1.76

The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J Mol Diagn (2000) 1.74

Cytogenetic analysis of six renal oncocytomas and a chromophobe cell renal carcinoma. Evidence that -Y, -1 may be a characteristic anomaly in renal oncocytomas. Cancer Genet Cytogenet (1992) 1.73

Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer (1997) 1.70

Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma. J Natl Cancer Inst (1999) 1.70

Mental symptoms in Parkinsonian patients treated with L-dopa. Lancet (1970) 1.69

Trends in severity of hospitalized myocardial infarction: the atherosclerosis risk in communities (ARIC) study, 1987-1994. Am Heart J (2000) 1.69

p53 expression in neurofibroma and malignant peripheral nerve sheath tumor. An immunohistochemical study of sporadic and NF1-associated tumors. Am J Clin Pathol (1996) 1.67

Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery (1996) 1.67

Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma. J Clin Oncol (1998) 1.65

Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology (1988) 1.65

Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer (1998) 1.65

Pigmented villonodular synovitis of the spine: a clinical, radiological, and morphological study of 12 cases. J Neurosurg (1996) 1.64

Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg (1993) 1.64

Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol (2001) 1.63

Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors. Am J Pathol (1997) 1.63

Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful? J Neurosurg (1995) 1.63

Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas. Int J Oncol (1998) 1.62

Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay. Am J Pathol (2001) 1.61

Extraventricular neurocytomas: pathologic features and clinical outcome. Am J Surg Pathol (2001) 1.59

Meningeal biopsy in intracranial hypotension: meningeal enhancement on MRI. Neurology (1995) 1.59

Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value. J Neurosurg (1997) 1.58

Management of malignant pineal germ cell tumors with residual mature teratoma. Neurosurgery (2001) 1.58

Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections. Mod Pathol (2001) 1.58

A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404. Int J Radiat Oncol Biol Phys (1999) 1.58

Malignant peripheral nerve sheath tumors with divergent differentiation. Cancer (1984) 1.57

Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clin Proc (1993) 1.57